Kathryn Shoemaker

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

Shuo Feng, Daniel J. Phillips, Thomas White et al. · Nature Medicine · 2021 · 1.2K citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

S Feng, Daniel J. Phillips, Thomas White et al. · medRxiv · 2021 · 166 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Phase 1 study of MEDI3902, an investigational anti–Pseudomonas aeruginosa PcrV and Psl bispecific human monoclonal antibody, in healthy adults

Omar Ali, Xiang‐Qing Yu, Gabriel J. Robbie et al. · Clinical Microbiology and Infection · 2018 · 132 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial

Jean Chastre, Bruno François, Marc Bourgeois et al. · Critical Care · 2022 · 93 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +17

Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trial

Bruno François, Hasan S. Jafri, Jean Chastre et al. · The Lancet Infectious Diseases · 2021 · 87 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +11